03:01 , Sep 1, 2018 |  BioCentury  |  Politics, Policy & Law

A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
18:57 , Aug 31, 2018 |  BC Week In Review  |  Company News

Ping An to apply AI to healthcare ecosystem

Mobile health and wellness company Ping An Healthcare and Technology Co. Ltd. (HKSE:1833) partnered with pharmaceutical distributor Jointown Pharmaceutical Group Co. Ltd. (Shanghai:600998) to develop an AI-based healthcare and pharmacy system for use in Chinese...
22:00 , Aug 30, 2018 |  BC Extra  |  Company News

Ping An to apply AI to healthcare ecosystem

Mobile health and wellness company Ping An Healthcare and Technology Co. Ltd. (HKSE:1833) partnered with pharmaceutical distributor Jointown Pharmaceutical Group Co. Ltd. (Shanghai:600998) to develop an AI-based healthcare and pharmacy system for use in Chinese...
05:29 , Jun 2, 2018 |  BioCentury  |  Strategy

Partnering on a mission

With a $260 million war chest and a banner roster of execs, advisors and deals, Brii Biosciences is pushing an agenda to bring infectious diseases to the forefront of innovation in China. Its top priority...
18:22 , May 25, 2018 |  BC Week In Review  |  Financial News

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on May 24 with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through...
12:24 , May 24, 2018 |  BC Extra  |  Company News

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on Thursday with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through commercialization...
18:05 , May 11, 2018 |  BC Week In Review  |  Company News

GSK China, JD.com in healthcare access deal

The GSK China unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) signed a memorandum of understanding with Chinese retailer JD.com Inc. (NASDAQ:JD) on May 8 to collaborate on developing "Internet + Healthcare" solutions for improving healthcare access...
19:22 , May 9, 2018 |  BC Extra  |  Company News

GSK China, JD.com in healthcare access deal

The GSK China unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) signed a memorandum of understanding with Chinese retailer JD.com Inc. (NASDAQ:JD) to collaborate on developing "Internet + Healthcare" solutions for improving healthcare access and affordability. The partnership...
22:19 , Mar 16, 2018 |  BioCentury  |  Finance

Hong Kong’s new chapter

Introducing a biotech chapter to the Hong Kong stock exchange fills a massive void in the region’s innovation ecosystem, but won’t come without risks. It promises to create a long sought public capital market for biotechs...
00:38 , Mar 16, 2018 |  BioCentury  |  Finance

Making the leap

The global ambitions of Chinese companies have lured at least three high-profile bankers to the C-suite in the past four months, and the trend is expected to continue. In December, Hua Medicine Ltd. hired George Lin...